FDA Drug Safety Communication: Ongoing safety review of Parkinson ’s drug Mirapex (pramipexole) and possible risk of heart failure

The U.S. Food and Drug Administration (FDA) is informing the public about a possible increased risk of heart failure with Mirapex (pramipexole), a drug used to treat Parkinson ’s disease and restless legs syndrome.

Source: FDA Center for Drug Evaluation and Research - What's New - June 26, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news